4//SEC Filing
AUBERTON-HERVE ANDRE-JACQUES 4
Accession 0001144204-18-040074
CIK 0001508381other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 1:55 PM ET
Size
6.2 KB
Accession
0001144204-18-040074
Insider Transaction Report
Form 4
AUBERTON-HERVE ANDRE-JACQUES
Director
Transactions
- Conversion
Common Stock
2018-07-24$0.05/sh+6,688,480$343,119→ 21,447,183 total(indirect: Shares held through Star SCI and 4A Consulting & Engineering)
Footnotes (2)
- [F1]Effective as of July 20, 2018, an aggregate amount of $308,807 in convertible promissory notes issued to Star SCI (the "Notes") converted in accordance with their terms into 6,688,480 shares of the Issuer's common stock. For purposes of the filing of this Form 4, the transaction date is deemed to be July 24, 2018, as that was the date that the Issuer preliminarily determined the number of shares of common stock that the Notes were convertible into in accordance with the terms of the Notes.
- [F2]The conversion price of the Notes was calculated using the VWAP (as defined in the Notes) average of the last 30 days before July 20, 2018. As of the date hereof, the Issuer has not definitively determined the conversion price. In the event that the Issuer definitively determines that the conversion price was lower than $0.0513, the Reporting Person will file an amendment to this Form 4 to reflect the correct conversion price, number of shares acquired upon conversion, and the amount of securities beneficially owned following the reported transaction.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001730329
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 1:55 PM ET
- Size
- 6.2 KB